reptides › skin › ghk-cu

ghk-cu

the copper peptide with the strongest skin evidence in the catalog. topical record first, injectable story thinner.

tier S · skin · 4,192 genes modulated

verdict

the copper peptide with the strongest cosmetic skin record on the site. the topical evidence is in front; the injectable story is a different conversation.

if you're asking about GHK-Cu for skin — topical formulations have 40+ years of cosmetic data behind them. mechanism is the carrier-plus-signal split: copper delivery to enzymes like lysyl oxidase that crosslinks collagen, plus gene expression changes affecting 4,000+ genes per the Pickart 2015 review. the ceiling is cosmetic-tier; on the order of mid-tier actives, below prescription retinoids on raw effect size. the 2025 permeation review is the useful corrective: formulation may matter as much as the ingredient label.

if you're asking about injectable GHK-Cu — the human evidence is thinner than the topical record. April 2026 brought a 503A category-2 removal for injectable GHK-Cu, with a separate FDA review window before February 2027. clinic protocols predate the trial data. the cosmetic-tier ceiling is the same; the injection changes the safety conversation, not the effect size.

if you came in about hair regrowth — mouse studies put GHK-Cu in the same range as minoxidil. the 2025 JAAD International Brown University protocol tattooed it in alongside minoxidil and dutasteride. clinical hair-count data is limited (a 7% bump at 16 weeks in one study). dermatologists trust it because it doesn't burn skin like a retinoid.

based on published evidence and disclosed clinical practice. not medical advice.

why S-tier

the most studied cosmetic peptide in history. pickart 1973: young plasma applied to aged liver cells made them behave young. five decades of topical research on collagen, wound healing, inflammation. cleanest safety profile in the catalog after 40+ years of cosmetic use. S because topical efficacy is documented and safety is exceptional. the asterisk: injectable GHK-Cu has a much thinner human evidence base.

the core tension

half the skincare industry runs on it. almost none of them use it at research-grade concentrations. the hair data is where the mouse work starts outperforming minoxidil.

what it is

glycine-histidine-lysine, chelated to one copper ion. it occurs naturally in plasma. levels drop from roughly 200 ng/mL at age 20 to 80 ng/mL at age 60. not a drug. regulated as a cosmetic ingredient. sold as topical serum by hundreds of brands and as research-grade injectable by peptide vendors.

what it does

two jobs in one molecule. the carrier function delivers copper to enzymes like lysyl oxidase, which crosslinks collagen. the signal function modulates gene expression. The original Connectivity Map analysis (Campbell JD et al. Genome Med 2012) flagged a tissue-regeneration expression signature. Pickart and Margolina's 2015 BioMed Res Int review reported expression changes affecting more than 4,000 genes tied to aging, healing, and regeneration. A 2026 C. elegans study extended this: GHK-Cu delays aging via mitochondrial regulation and DAF-16/SKN-1 activation. invertebrate model. not human. topical human trials show real but modest gains in firmness, 25% faster epithelial recovery after fractional laser, and a 7% hair-count bump at 16 weeks.

origin

Loren Pickart, UCSF, 1973, while a graduate student. he took plasma from young donors, dripped it on aged human liver cells, and watched them resume making proteins like younger cells. the active factor was a tripeptide. his lab pinned down the copper affinity in 1980. mainstream science caught up in 2014 with the gene expression work. four decades before the parabiosis papers got famous.

why researchers are interested

it works. the molecule is real, the mechanism is real, the topical safety record is clean after 40+ years on shelves. the hair data is where it gets interesting. mouse studies put GHK-Cu level with or ahead of minoxidil. the 2025 JAAD International Brown University protocol tattooed it in alongside minoxidil and dutasteride. dermatologists trust it because it doesn't burn skin like a retinoid.

does it work

yes, with calibrated expectations. topical evidence is strong. dozens of mechanistic studies, multiple clinical trials, post-laser healing data, hair density data. one of the few peptides where the science actually supports the marketing. the ceiling is cosmetic-tier. equivalent to mid-tier cosmetic actives, below prescription retinoids on raw effect size. injectable use has thinner human evidence. the 2025 permeation review is the useful corrective. the molecule is hydrophilic. the bottle still has to solve skin penetration. formulation may matter as much as the ingredient label.

claims vs the data

  • stimulates collagen production — supported — dozens of in vitro and ex vivo studies. clinical topical trials show 15-25% improvements in firmness metrics.
  • accelerates wound healing — supported — animal models consistently show 30-50% faster wound closure. post-laser-resurfacing trial in humans showed 25% faster epithelial recovery.
  • reverses aging — overreach — modulates gene expression relevant to aging. does not "reverse" aging. topical application affects skin appearance, not systemic aging processes.
  • grows hair — partially true — Japanese trial 2025 with 0.02% peptide lotion: 7% increase in hair count at 16 weeks. mild effect, below minoxidil-tier.
  • safer than retinoids — supported — minimal irritation profile. compatible with sensitive skin. four decades of topical use without significant adverse events.
  • gene expression effects (more than 4,000 genes) — supported — Pickart Margolina 2015 BioMed Res Int reported expression changes affecting more than 4,000 genes; the original Campbell 2012 Connectivity Map analysis flagged a tissue-regeneration signature. Mechanism is real, though clinical translation is cosmetic-scale, not proof that topical products rewrite thousands of genes in vivo.
  • injectable is more effective than topical — weak — far fewer injectable trials. mechanism reasonable but human evidence base is thin compared to topical.

key facts

  • molecular formula: C₁₄H₂₄CuN₆O₄ (Cu-GHK complex)
  • molecular weight: 403.9 g/mol for the 1:1 Cu-GHK complex; free GHK is about 340.4 g/mol
  • amino acids: 3 (GHK) + Cu²⁺
  • half-life: plasma: minutes (rapidly peptidase-cleared); the ~12h figure is tissue detectability, not a plasma half-life
  • type: tripeptide-copper complex
  • CAS: 49557-75-7
  • 1973 discovery (pickart)
  • 200ng→80ng plasma GHK: age 20→60
  • 50+ clinical/mechanistic studies
  • topical strongest evidence route

frequently asked questions

What is GHK-Cu?

GHK-Cu is a naturally occurring copper-bound tripeptide (glycine-histidine-lysine plus copper). Discovered by Loren Pickart in the 1970s, it is widely used in cosmetic formulations for skin repair and anti-aging applications.

What does GHK-Cu do?

GHK-Cu has demonstrated wound-healing, collagen-stimulating, and anti-aging effects across numerous in vitro and small clinical studies. It modulates gene expression in fibroblasts and promotes dermal remodeling. The topical evidence base is the most established; injectable use in the research peptide community has less clinical validation.

How is GHK-Cu typically administered?

GHK-Cu is most commonly applied topically in cosmetic formulations, usually serums or creams. Research peptide vendors also sell injectable GHK-Cu, but the topical form has the cleaner clinical record. Injectable use sits mostly in research-peptide culture, not in a well-mapped clinical evidence base.

What are the side effects of GHK-Cu?

Topical GHK-Cu is well-tolerated, with occasional mild skin irritation at higher concentrations. Injectable GHK-Cu can cause injection-site pigmentation (transient blue-green coloring from the copper component) and soreness. Systemic side effects are uncommon at typical doses.

Is GHK-Cu FDA approved?

No. GHK-Cu has no FDA drug approval. It is classified as a cosmetic ingredient and is legal in skincare products. Injectable GHK-Cu is sold as a research chemical and is not FDA-approved for human use.

How much does GHK-Cu cost?

Topical GHK-Cu cosmetic products retail at $30-100+ per bottle depending on formulation and concentration. Injectable research-grade GHK-Cu is inexpensive on the research-chemical market.

related peptides

  • glow — GHK-Cu dominates this 3-peptide blend (50mg)
  • klow — GHK-Cu + BPC-157 + TB-500 + KPV blend
  • bpc-157 — often stacked for tissue repair
  • tb-500 — often stacked for soft-tissue regeneration

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.